Farallon Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EA
Electronic Arts
EA
|
+$492M |
| 2 |
Broadcom
AVGO
|
+$292M |
| 3 |
KKR & Co
KKR
|
+$280M |
| 4 |
Roivant Sciences
ROIV
|
+$248M |
| 5 |
Mastercard
MA
|
+$138M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$650M |
| 2 |
CYBR
CyberArk
CYBR
|
+$470M |
| 3 |
Salesforce
CRM
|
+$334M |
| 4 |
Nasdaq
NDAQ
|
+$290M |
| 5 |
RNAM
Avidity Biosciences
RNAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.53% |
| 2 | Communication Services | 11.31% |
| 3 | Financials | 11.23% |
| 4 | Technology | 10.28% |
| 5 | Consumer Discretionary | 4.69% |
Similar funds
Farallon Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Farallon Capital Management held 204 positions worth $19.1B, down 17% from $23.1B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Farallon Capital Management withdrew a net $3.24B in Q1 2026, closing 31 positions and reducing 30 holdings. Its most notable exit was Exact Sciences, an estimated $650M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 41% a quarter earlier, followed by Communication Services and Financials.
Against the trend, Farallon Capital Management opened a new position in Dianthus Therapeutics worth $70.2M.
- Farallon Capital Management's largest Q1 2026 buy was Dianthus Therapeutics: 836,000 shares worth $70.2M.
- Farallon Capital Management added most to Electronic Arts in Q1 2026, an estimated $492M increase.
- Farallon Capital Management's biggest Q1 2026 reduction was Wabtec, cutting an estimated $210M.
- Farallon Capital Management fully exited Exact Sciences in Q1 2026, selling an estimated $650M.
- Farallon Capital Management's ten largest holdings make up 50% of its $19.1B portfolio in Q1 2026.
- Farallon Capital Management opened 48 new positions and closed 31 in Q1 2026.
- Farallon Capital Management's portfolio value fell 17% quarter-over-quarter to $19.1B.
Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.